@prefix this: . @prefix rdfs: . @prefix xsd: . @prefix sio: . @prefix ncit: . @prefix lld: . @prefix miriam-gene: . @prefix miriam-pubmed: . @prefix eco: . @prefix wi: . @prefix prov: . @prefix pav: . @prefix prv: . @prefix dcterms: . @prefix np: . @prefix dgn-np: . @prefix dgn-gda: . @prefix dgn-void: . dgn-np:NP485859.RAPYeU01oUTOBDSCpsnHVWpgPmfFujJxsXriptbwmwdWc130_head { this: np:hasAssertion dgn-np:NP485859.RAPYeU01oUTOBDSCpsnHVWpgPmfFujJxsXriptbwmwdWc130_assertion; np:hasProvenance dgn-np:NP485859.RAPYeU01oUTOBDSCpsnHVWpgPmfFujJxsXriptbwmwdWc130_provenance; np:hasPublicationInfo dgn-np:NP485859.RAPYeU01oUTOBDSCpsnHVWpgPmfFujJxsXriptbwmwdWc130_publicationInfo; a np:Nanopublication . dgn-np:NP485859.RAPYeU01oUTOBDSCpsnHVWpgPmfFujJxsXriptbwmwdWc130_assertion a np:Assertion . dgn-np:NP485859.RAPYeU01oUTOBDSCpsnHVWpgPmfFujJxsXriptbwmwdWc130_provenance a np:Provenance . dgn-np:NP485859.RAPYeU01oUTOBDSCpsnHVWpgPmfFujJxsXriptbwmwdWc130_publicationInfo a np:PublicationInfo . } dgn-np:NP485859.RAPYeU01oUTOBDSCpsnHVWpgPmfFujJxsXriptbwmwdWc130_assertion { miriam-gene:3490 a ncit:C16612 . lld:C0678222 a ncit:C7057 . dgn-gda:DGN547c41c1b402870ea10442013bc07572 sio:SIO_000628 miriam-gene:3490, lld:C0678222; a sio:SIO_001121 . } dgn-np:NP485859.RAPYeU01oUTOBDSCpsnHVWpgPmfFujJxsXriptbwmwdWc130_provenance { dgn-np:NP485859.RAPYeU01oUTOBDSCpsnHVWpgPmfFujJxsXriptbwmwdWc130_assertion dcterms:description "[The cDNA-oligoarray analysis and reverse transcription-PCR verification indicated common changes in gene expression in methionine-dependent cell lines to include up-regulation/induction of cyclin D1, mitotic arrest deficient (MAD)1, p21, growth arrest and DNA-damage-inducible (GADD)45 alpha, GADD45 gamma, GADD34, breast cancer (BRCA)1, 14-3-3sigma, B-cell CLL/lymphoma (BCL)1, transforming growth factor (TGF)-beta, TGF-beta-induced early response (TIEG), SMAD5, SMAD7, SMAD2, insulin-like growth factor binding protein (IGFBP7), IGF-R2, vascular endothelial growth factor (VEGF), TNF-related apoptosis-inducing ligand (TRAIL), TNF-alpha converting enzyme (TACE), TRAIL receptor (TRAIL-R)2, TNFR-related death receptor (DR)6, TRAF interacting protein (I-TRAF), IL-6, MDA7, IL-1B convertase (ICE)-gamma, delta and epsilon, IRF1, IRF5, IRF7, interferon (IFN)-gamma and receptor components, ISG15, p65-NF-kappaB, JUN-B, positive cofactor (PC)4, C/ERB-beta, inositol triphosphate receptor I, and methionine adenosyltransferase II.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en; wi:evidence dgn-void:source_evidence_literature; sio:SIO_000772 miriam-pubmed:15492278; prov:wasDerivedFrom dgn-void:befree-20150227; prov:wasGeneratedBy eco:ECO_0000203 . dgn-void:befree-20150227 pav:importedOn "2015-02-27"^^xsd:date . dgn-void:source_evidence_literature a eco:ECO_0000212; rdfs:comment "Gene-disease associations inferred from text-mining the literature."@en; rdfs:label "DisGeNET evidence - LITERATURE"@en . } dgn-np:NP485859.RAPYeU01oUTOBDSCpsnHVWpgPmfFujJxsXriptbwmwdWc130_publicationInfo { this: dcterms:created "2015-08-25T14:42:26+02:00"^^xsd:dateTime; dcterms:rights ; dcterms:rightsHolder dgn-void:IBIGroup; dcterms:subject sio:SIO_000983; prv:usedData dgn-void:disgenetv3.0rdf; pav:authoredBy , , , , ; pav:createdBy ; pav:version "v3.0.0.0" . dgn-void:disgenetv3.0rdf pav:version "v3.0.0" . }